SUN PHARMACEUTICAL INDUSTRIES Financial Statement Analysis
[BOM: 524715|NSE : SUNPHARMA]

The Revenues of SUN PHARMACEUTICAL INDUSTRIES have increased by 2.01% YoY.
The Earnings Per Share (EPS) of SUN PHARMACEUTICAL INDUSTRIES has decreased by -22.88 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

SUN PHARMACEUTICAL INDUSTRIES Last 5 Annual Financial Results
[BOM: 524715|NSE : SUNPHARMA]

ConsolidatedMar2021
Mar2020
Mar2019
Mar2018
Mar2017
Revenues ₹33,498 Cr₹32,838 Cr₹29,066 Cr₹26,416 Cr₹31,308 Cr
Expenses ₹25,030 Cr₹25,863 Cr₹22,792 Cr₹20,881 Cr₹21,626 Cr
Operating Profit (Excl OI) ₹8,468 Cr₹6,974 Cr₹6,274 Cr₹5,535 Cr₹9,682 Cr
Other Income ₹859 Cr₹652 Cr₹1,059 Cr₹912 Cr₹1,030 Cr
Interest ₹141 Cr₹303 Cr₹555 Cr₹518 Cr₹400 Cr
Depreciation ₹2,080 Cr₹2,053 Cr₹1,753 Cr₹1,500 Cr₹1,265 Cr
Profit Before Tax ₹2,799 Cr₹5,010 Cr₹3,810 Cr₹3,479 Cr₹9,048 Cr
Profit After Tax ₹2,285 Cr₹4,187 Cr₹3,209 Cr₹2,568 Cr₹7,836 Cr
Consolidated Net Profit ₹2,904 Cr₹3,765 Cr₹2,665 Cr₹2,096 Cr₹6,964 Cr
Earnings Per Share (Rs)₹12.10₹15.69₹11.11₹8.73₹29.03
PAT Margin (%)3.727.055.705.0224.82
ROE(%)4.989.668.056.8522.51
ROCE(%)5.6710.088.688.4021.48
Total Debt/Equity(x)0.080.180.250.270.27
Key Financials
Market Cap : ₹ 216,884.7 Cr
Revenue (TTM) : ₹ 37,730.7 Cr
Net Profit(TTM) : ₹ 6,476.2 Cr
EPS (TTM) : ₹ 27.0
P/E (TTM) : 33.5

Industry Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES -1.9% -0.2% 29.4%
DIVIS LABORATORIES -9.8% -22.2% -15.5%
DR REDDYS LABORATORIES 2.8% 7.7% -17.4%
CIPLA -0.4% -1.1% 3.1%
GLAND PHARMA -2.5% -7.7% -13%
PIRAMAL ENTERPRISES -12.8% -23.8% 9.1%
CADILA HEALTHCARE 3.1% 8.4% -40.1%
TORRENT PHARMACEUTICALS 12.4% 8.5% 6.5%
ALKEM LABORATORIES 1.9% -7.9% 4.1%


SUN PHARMACEUTICAL INDUSTRIES Revenues
[BOM: 524715|NSE : SUNPHARMA]

Y-o-Y

2.01 %

5 Yr CAGR

1.70 %

Years Revenues % Change
Mar2021 ₹33,498 Cr
2.01
Mar2020 ₹32,838 Cr
12.98
Mar2019 ₹29,066 Cr
10.03
Mar2018 ₹26,416 Cr
-15.63
Mar2017 ₹31,308 Cr -


SUN PHARMACEUTICAL INDUSTRIES Operating Profit
[BOM: 524715|NSE : SUNPHARMA]

Y-o-Y

21.42 %

5 Yr CAGR

-3.30 %

Years Operating Profit % Change
Mar2021 ₹8,468 Cr
21.42
Mar2020 ₹6,974 Cr
11.17
Mar2019 ₹6,274 Cr
13.35
Mar2018 ₹5,535 Cr
-42.84
Mar2017 ₹9,682 Cr -

Operating Margins
Y-o-Y

19.02 %

5 Yr CAGR

-4.92 %

Years Operating Margin% % Change
Mar2021 25.28%
19.02
Mar2020 21.24%
-1.58
Mar2019 21.58%
3.01
Mar2018 20.95%
-32.27
Mar2017 30.93% -

SUN PHARMACEUTICAL INDUSTRIES Profit After Tax
[BOM: 524715|NSE : SUNPHARMA]

Y-o-Y

-22.87 %

5 Yr CAGR

-19.64 %

Years Profit After Tax % Change
Mar2021 ₹2,904 Cr
-22.87
Mar2020 ₹3,765 Cr
41.25
Mar2019 ₹2,665 Cr
27.19
Mar2018 ₹2,096 Cr
-69.91
Mar2017 ₹6,964 Cr -

PAT Margins
Y-o-Y

-47.23 %

5 Yr CAGR

-37.78 %

Years PAT Margin(%) % Change
Mar2021 3.72 %
-47.23
Mar2020 7.05 %
23.68
Mar2019 5.7 %
13.55
Mar2018 5.02 %
-79.77
Mar2017 24.82 % -

SUN PHARMACEUTICAL INDUSTRIES Earnings Per Share (EPS)
[BOM: 524715|NSE : SUNPHARMA]

Y-o-Y

-22.88 %

5 Yr CAGR

-19.65 %

Years EPS % Change
Mar2021 ₹12
-22.88
Mar2020 ₹16
41.22
Mar2019 ₹11
27.26
Mar2018 ₹8.73
-69.93
Mar2017 ₹29 -

SUN PHARMACEUTICAL INDUSTRIES Return on Capital Employed (ROCE)
[BOM: 524715|NSE : SUNPHARMA]

Y-o-Y

-43.75 %

5 Yr CAGR

-28.32 %

Years ROCE % Change
Mar2021 5.67%
-43.75
Mar2020 10.08%
16.13
Mar2019 8.68%
3.33
Mar2018 8.4%
-60.89
Mar2017 21.48% -

SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex

Current Share Price : ₹904.0
Current MarketCap: ₹ 216,884.7 Cr
Updated EOD on :May 27,2022

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

-1.9%

-0.2%

29.4%

SENSEX

1%

-4.3%

8.4%

SUN PHARMACEUTICAL INDUSTRIES related INDICES

BSE Indices1W1M1Y
S&P BSE SENSEX 1% -4.3% 8.4%
S&P BSE 100 ESG INDEX 0.6% -5.8% 8.5%
S&P BSE SENSEX50 0.5% -4.9% 7.7%
S&P BSE GREENEX 0.4% -8% 10%
S&P BSE 100 0.3% -6% 7.6%
S&P BSE CARBONEX 0.3% -5.9% 7.6%
S&P BSE 100 LARGECAP TMC 0.2% -6.1% 7.1%
S&P BSE LARGECAP 0.2% -5.9% 7.6%
S&P BSE LARGE MIDCAP 0.2% -6.3% 7.1%
S&P BSE 200 0.2% -6.3% 7.2%
NSE Indices1W1M1Y
NIFTY GROWTH SECTOR 15 1.2% -0.2% 2.8%
NIFTY 50 0.5% -4.9% 7.6%
NIFTY 100 0.2% -6% 6.9%
NIFTY 200 0.1% -6.4% 7.1%
NIFTY 500 -0.2% -6.9% 7%
NIFTY LARGE MIDCAP 250 -0.3% -7.2% 7.4%
NIFTY50 EQUAL WEIGHT -0.4% -6.2% 7.8%
NIFTY 100 EQUAL WEIGHT -0.6% -8.4% 4.1%
NIFTY100 LIQ 15 -0.7% -10.1% 7.2%
NIFTY500 MULTICAP 50:25:25 -0.8% -8.3% 7.2%

You may also like the below Video Courses


FAQ about SUN PHARMACEUTICAL INDUSTRIES Financials


How the annual revenues of SUN PHARMACEUTICAL INDUSTRIES have changed ?

The Revenues of SUN PHARMACEUTICAL INDUSTRIES have increased by 2.01% YoY .

How the Earnings per Share (EPS) of SUN PHARMACEUTICAL INDUSTRIES have changed?

The Earnings Per Share (EPS) of SUN PHARMACEUTICAL INDUSTRIES has decreased by -22.88 % YoY .



SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z